DDIT3 and diffuse large B-cell lymphoma: Of the 1537 patients with DLBCL, 119 patients at stage IV with extranodal involvement who had achieved CR by the sixth cycle of R‐CHOP were eligible for the study; the detailed study design is shown in Figure 1.